Cigna Group (CI) stock
CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3021% below fair value
$301.45−1.68 (-0.55%)
Close on Nov 11, 2026Market cap $79.66BP/E 13.3Yield 2.00%
Cigna ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cigna's ebitda for the twelve months ending Sep 30, 2026 was $12.67B, up 8.0% year over year. For fiscal 2025 it was $11.98B, down 1.8% from the year before. The highest annual figure on record is $12.19B in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.98B | -1.8% |
| FY2024 | Dec 31, 2024 | $12.19B | +5.4% |
| FY2023 | Dec 31, 2023 | $11.57B | +1.6% |
| FY2022 | Dec 31, 2022 | $11.39B | +4.8% |
| FY2021 | Dec 31, 2021 | $10.86B | -0.8% |
| FY2020 | Dec 31, 2020 | $10.96B | -6.6% |
| FY2019 | Dec 31, 2019 | $11.73B | +141.6% |
| FY2018 | Dec 31, 2018 | $4.86B | +7.7% |
| FY2017 | Dec 31, 2017 | $4.51B | +21.9% |
| FY2016 | Dec 31, 2016 | $3.70B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.26B | -0.4% |
| Q2 FY2026 | Jun 30, 2026 | $3.33B | +11.5% |
| Q1 FY2026 | Mar 31, 2026 | $3.01B | +13.7% |
| Q4 FY2025 | Dec 31, 2025 | $3.07B | +8.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.28B | +1.5% |
| Q2 FY2025 | Jun 30, 2025 | $2.99B | -5.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.65B | -11.7% |
| Q4 FY2024 | Dec 31, 2024 | $2.82B | -0.2% |
| Q3 FY2024 | Sep 30, 2024 | $3.23B | +7.3% |
| Q2 FY2024 | Jun 30, 2024 | $3.15B | +5.8% |
| Q1 FY2024 | Mar 31, 2024 | $3.00B | +8.4% |
| Q4 FY2023 | Dec 31, 2023 | $2.83B | +13.7% |
| Q3 FY2023 | Sep 30, 2023 | $3.01B | +4.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.98B | -4.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.76B | -4.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.48B | +8.7% |
| Q3 FY2022 | Sep 30, 2022 | $2.87B | -5.3% |
| Q2 FY2022 | Jun 30, 2022 | $3.13B | +8.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.91B | +8.7% |
| Q4 FY2021 | Dec 31, 2021 | $2.29B | +11.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.03B | +7.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.88B | -13.7% |
| Q1 FY2021 | Mar 31, 2021 | $2.67B | -3.0% |
| Q4 FY2020 | Dec 31, 2020 | $2.06B | -17.3% |
| Q3 FY2020 | Sep 30, 2020 | $2.81B | -7.4% |
| Q2 FY2020 | Jun 30, 2020 | $3.33B | +8.3% |
| Q1 FY2020 | Mar 31, 2020 | $2.75B | -11.9% |
| Q4 FY2019 | Dec 31, 2019 | $2.49B | +204.9% |
| Q3 FY2019 | Sep 30, 2019 | $3.04B | +134.6% |
| Q2 FY2019 | Jun 30, 2019 | $3.08B | +137.2% |
| Q1 FY2019 | Mar 31, 2019 | $3.13B | +116.0% |
| Q4 FY2018 | Dec 31, 2018 | $816.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.29B | – |
| Q2 FY2018 | Jun 30, 2018 | $1.30B | – |
| Q1 FY2018 | Mar 31, 2018 | $1.45B | – |
See a number that looks wrong?